Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Tessa Romero's Stock Ratings
JP Morgan Analyst
Tessa Romero is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
23.2%
Smart Score
Overall Average Return Percentile
80th
Number of Ratings
82
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/21/2025 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | -25.51% | $37 → $20 | Maintains | Neutral | Get Alert | |
| 11/20/2025 | BHVN | Buy Now | Biohaven | $11.10 | 35.14% | $47 → $15 | Maintains | Overweight | Get Alert | |
| 11/18/2025 | XENE | Buy Now | Xenon Pharmaceuticals | $43.60 | 37.61% | $57 → $60 | Maintains | Overweight | Get Alert | |
| 11/18/2025 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | 3.89% | $46 → $47 | Maintains | Overweight | Get Alert | |
| 11/18/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.42 | 7590.06% | $261 → $263 | Downgrade | Overweight → Underweight | Get Alert | |
| 11/17/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 14.74% | $33 → $31 | Maintains | Overweight | Get Alert | |
| 11/14/2025 | DYN | Buy Now | Dyne Therapeutics | $19.59 | -13.22% | $18 → $17 | Maintains | Neutral | Get Alert | |
| 11/14/2025 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 42.2% | $33 → $34 | Maintains | Overweight | Get Alert | |
| 09/29/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 22.14% | $34 → $33 | Maintains | Overweight | Get Alert | |
| 09/16/2025 | NMRA | Buy Now | Neumora Therapeutics | $1.94 | — | — | Downgrade | Neutral → Underweight | Get Alert | |
| 08/19/2025 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 25.47% | $40 → $30 | Maintains | Overweight | Get Alert | |
| 07/24/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 25.85% | $30 → $34 | Maintains | Overweight | Get Alert | |
| 07/15/2025 | DYN | Buy Now | Dyne Therapeutics | $19.59 | -54.06% | $10 → $9 | Maintains | Neutral | Get Alert | |
| 06/18/2025 | BHVN | Buy Now | Biohaven | $11.10 | 395.5% | $68 → $55 | Maintains | Overweight | Get Alert | |
| 06/09/2025 | CYTK | Buy Now | Cytokinetics | $64.34 | -17.62% | $71 → $53 | Maintains | Overweight | Get Alert | |
| 06/06/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 11.04% | $26 → $30 | Maintains | Overweight | Get Alert | |
| 05/30/2025 | LXEO | Buy Now | Lexeo Therapeutics | $9.90 | 1.01% | $16 → $10 | Maintains | Overweight | Get Alert | |
| 05/16/2025 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 67.29% | $45 → $40 | Maintains | Overweight | Get Alert | |
| 05/16/2025 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -3.77% | $25 → $26 | Maintains | Overweight | Get Alert | |
| 03/21/2025 | DYN | Buy Now | Dyne Therapeutics | $19.59 | -13.22% | $18 → $17 | Maintains | Neutral | Get Alert | |
| 03/05/2025 | BHVN | Buy Now | Biohaven | $11.10 | 512.61% | $72 → $68 | Maintains | Overweight | Get Alert | |
| 11/05/2024 | UPB | Buy Now | Upstream Bio | $27.20 | 39.71% | → $38 | Initiates | → Overweight | Get Alert | |
| 11/05/2024 | NMRA | Buy Now | Neumora Therapeutics | $1.94 | 673.2% | $18 → $15 | Downgrade | Overweight → Neutral | Get Alert | |
| 10/24/2024 | DYN | Buy Now | Dyne Therapeutics | $19.59 | 78.66% | $43 → $35 | Downgrade | Overweight → Neutral | Get Alert | |
| 10/24/2024 | MCRB | Buy Now | Seres Therapeutics | $17.00 | — | — | Downgrade | Neutral → Underweight | Get Alert | |
| 10/14/2024 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -31.48% | $18 → $31 | Maintains | Overweight | Get Alert | |
| 10/03/2024 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -60.21% | $20 → $18 | Maintains | Overweight | Get Alert | |
| 10/03/2024 | BHVN | Buy Now | Biohaven | $11.10 | 512.61% | $55 → $68 | Maintains | Overweight | Get Alert | |
| 09/05/2024 | CYTK | Buy Now | Cytokinetics | $64.34 | 10.35% | $65 → $71 | Maintains | Overweight | Get Alert | |
| 08/13/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $16.50 | 75.76% | $32 → $29 | Maintains | Overweight | Get Alert | |
| 08/12/2024 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 29.65% | $30 → $31 | Maintains | Overweight | Get Alert | |
| 07/09/2024 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 25.47% | $27 → $30 | Maintains | Overweight | Get Alert | |
| 07/09/2024 | DYN | Buy Now | Dyne Therapeutics | $19.59 | 119.5% | $39 → $43 | Maintains | Overweight | Get Alert | |
| 06/24/2024 | CYTK | Buy Now | Cytokinetics | $64.34 | 1.03% | $77 → $65 | Maintains | Overweight | Get Alert | |
| 06/13/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 71.32% | → $46 | Reinstates | Neutral → Neutral | Get Alert | |
| 06/04/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $16.50 | 93.94% | $35 → $32 | Maintains | Overweight | Get Alert | |
| 03/25/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -7.47% | $29 → $25 | Maintains | Overweight | Get Alert | |
| 03/18/2024 | NMRA | Buy Now | Neumora Therapeutics | $1.94 | 1034.02% | $20 → $22 | Maintains | Overweight | Get Alert | |
| 03/07/2024 | CYTK | Buy Now | Cytokinetics | $64.34 | 19.68% | $78 → $77 | Maintains | Overweight | Get Alert | |
| 03/01/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 7.34% | $32 → $29 | Maintains | Overweight | Get Alert | |
| 02/23/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 11.73% | $31 → $30 | Maintains | Neutral | Get Alert | |
| 02/23/2024 | BHVN | Buy Now | Biohaven | $11.10 | 404.5% | $32 → $56 | Maintains | Overweight | Get Alert | |
| 01/23/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 15.46% | $30 → $31 | Maintains | Neutral | Get Alert | |
| 01/22/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $16.50 | 112.12% | → $35 | Initiates | → Overweight | Get Alert | |
| 11/28/2023 | LXEO | Buy Now | Lexeo Therapeutics | $9.90 | 102.02% | → $20 | Initiates | → Overweight | Get Alert | |
| 11/20/2023 | BHVN | Buy Now | Biohaven | $11.10 | 188.29% | $26 → $32 | Maintains | Overweight | Get Alert | |
| 11/08/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 11.73% | $32 → $30 | Maintains | Neutral | Get Alert | |
| 11/08/2023 | NMRA | Buy Now | Neumora Therapeutics | $1.94 | 930.93% | $21 → $20 | Maintains | Overweight | Get Alert | |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $1.94 | 982.47% | → $21 | Initiates | → Overweight | Get Alert | |
| 10/10/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 18.44% | $29 → $32 | Upgrade | Neutral → Overweight | Get Alert | |
| 08/22/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $8 → $7 | Maintains | Underweight | Get Alert | |
| 08/16/2023 | BHVN | Buy Now | Biohaven | $11.10 | 116.22% | $27 → $24 | Maintains | Overweight | Get Alert | |
| 08/09/2023 | DYN | Buy Now | Dyne Therapeutics | $19.59 | 12.3% | $20 → $22 | Maintains | Overweight | Get Alert | |
| 08/07/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | 7.34% | $28 → $29 | Maintains | Neutral | Get Alert | |
| 08/07/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 19.18% | $33 → $32 | Maintains | Neutral | Get Alert | |
| 06/30/2023 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 4.56% | $24 → $25 | Maintains | Overweight | Get Alert | |
| 05/16/2023 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 0.38% | $25 → $24 | Maintains | Overweight | Get Alert | |
| 04/25/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $43.60 | 26.15% | $54 → $55 | Maintains | Overweight | Get Alert | |
| 04/21/2023 | MCRB | Buy Now | Seres Therapeutics | $17.00 | -58.82% | → $7 | Initiates | → Neutral | Get Alert | |
| 03/20/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -22.27% | $19 → $21 | Maintains | Neutral | Get Alert | |
| 03/20/2023 | CYTK | Buy Now | Cytokinetics | $64.34 | -19.18% | $55 → $52 | Maintains | Overweight | Get Alert | |
| 02/28/2023 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 4.56% | $27 → $25 | Maintains | Overweight | Get Alert | |
| 01/04/2023 | BHVN | Buy Now | Biohaven | $11.10 | 107.21% | → $23 | Initiates | → Overweight | Get Alert | |
| 12/01/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $26.85 | 22.91% | $48 → $33 | Maintains | Neutral | Get Alert | |
| 11/29/2022 | DYN | Buy Now | Dyne Therapeutics | $19.59 | -8.12% | $24 → $18 | Maintains | Overweight | Get Alert | |
| 11/18/2022 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -55.79% | $38 → $20 | Maintains | Overweight | Get Alert | |
| 11/14/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $27.02 | -37.08% | $19 → $17 | Maintains | Neutral | Get Alert | |
| 10/31/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $16 → $7 | Downgrade | Neutral → Underweight | Get Alert | |
| 07/21/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $43.60 | 26.15% | → $55 | Initiates | → Overweight | Get Alert | |
| 06/28/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $39 → $36 | Maintains | Neutral | Get Alert | |
| 05/24/2022 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | -18.21% | $46 → $37 | Maintains | Overweight | Get Alert | |
| 02/14/2022 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 33.84% | $33 → $32 | Maintains | Overweight | Get Alert | |
| 01/06/2022 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 38.02% | $30 → $33 | Maintains | Overweight | Get Alert | |
| 01/03/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $30 → $27 | Maintains | Neutral | Get Alert | |
| 11/16/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $57 → $30 | Downgrade | Overweight → Neutral | Get Alert | |
| 06/28/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | → $36 | Downgrade | Overweight → Neutral | Get Alert | |
| 04/20/2021 | EWTX | Buy Now | Edgewise Therapeutics | $23.91 | 42.2% | → $34 | Initiates | → Overweight | Get Alert | |
| 03/22/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $52 | Assumes | → Overweight | Get Alert | |
| 03/02/2021 | ORTX | Buy Now | Orchard Therapeutics | — | — | $14 → $15 | Assumes | → Overweight | Get Alert | |
| 01/06/2021 | SRRK | Buy Now | Scholar Rock Holding | $45.24 | 30.42% | → $59 | Initiates | → Overweight | Get Alert | |
| 12/17/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | $58 → $79 | Maintains | Equal-Weight | Get Alert | |
| 01/04/2017 | GBT | Buy Now | Global Blood Therapeutics | — | — | → $25 | Initiates | → Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved